Pretreatment neutrophil‐to‐lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration‐sensitive prostate cancer

BACKGROUND: Although the prognostic role of neutrophil‐to‐lymphocyte ratio (NLR) has been assessed in patients with metastatic castration‐resistant prostate cancer, data on its impact on oncological outcomes of patients with metastatic castration‐sensitive prostate cancer (mCSPC) are scarce. AIM: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Salah, Samer, Abu‐Hijlih, Ramiz, Abuhijla, Fawzi, Tamimi, Faris, Al‐Tell, Abdallah, Shahait, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551990/
https://www.ncbi.nlm.nih.gov/pubmed/34159754
http://dx.doi.org/10.1002/cnr2.1392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551990/
https://www.ncbi.nlm.nih.gov/pubmed/34159754
http://dx.doi.org/10.1002/cnr2.1392

Ejemplares similares